Summary:
The purpose of this study is to assess ALD403 in the prevention of migraine headache in chronic migraineurs.
Qualified Participants Must:
Be between 18 and 55 years of age
Qualified Participants May Receive:
Study-related medical care and study medication at no cost and may be compensated for time and travel.